RecruitingPHASE4NCT05547048

Integrated eHealth for HIV and Substance Use Disorders in Justice Involved Women

Sponsor: Yale University

Trial Details

Condition	HIV, Opioid Use Disorder, eHealth
Intervention	Decision Aid; Athena strategy
Phase	PHASE4
Status	Recruiting
Participants	250
Est. Completion	1 June 2027
Last Updated	20 May 2026

Primary Outcome

Number of participants who initiate PrEP

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: * woman * have access to a working mobile or landline phone * Lifetime CJ-involvement (probation, parole, intensive pretrial or community supervision, or release from prison/jail) * are confirmed HIV-negative by point-of-care 3rd generation HIV antibody test * meet clinical criteria for PrEP * have opioid use disorder (regardless of baseline treatment status) Exclusion Criteria: * unable or unwilling to provide informed consent * pregnant or breast-feeding * currently taking PrEP at the time of study enrollment * not comfortable conversing in English or Spanish.

Trial Sites

Countries

United States

View Registry Entry

Related Analysis

Phase IV Trial Tests Integrated eHealth Platform for HIV Prevention and Opioid Treatment in Justice-Involved Women

Yale University researchers are testing an innovative integrated eHealth platform combining HIV prevention and opioid treatment for justice-involved women. The Phase IV trial compares digital health interventions against standard decision aids to improve care access in this vulnerable population.

Read full article →

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service